Journal Home
Search for

Volume 93, Issue 2, Pages 467-474 (15 January 2010)


View previous. 24 of 56 View next.

Vitrification of oocytes produces high pregnancy rates when carried out in fertile women

Thomas J. Kim, M.D.abc, Larry R. Laufer, M.D.b, Seung Wook Hong, M.Sc.cdCorresponding Author Informationemail address

Received 3 October 2008; received in revised form 17 December 2008; accepted 18 December 2008. published online 12 February 2009.

Objective

To determine the efficiency of our vitrification technique when applied in young fertile women.

Design

Clinical research and application.

Setting

In vitro fertilization center.

Patient(s)

Twenty-one women were recruited from the navy community with 19 patients finishing the study.

Intervention(s)

Vitrified oocytes with use of the electron microscopic grid method were warmed 6 months after vitrification. Surviving metaphase II oocytes were microinjected for fertilization, and clinical results were evaluated.

Main Outcome Measure(s)

Survival, fertilization, and cleavage rate. Pregnancy and implantation rate.

Result(s)

Three hundred ninety-five oocytes were warmed, of which 320 oocytes (81.0%) survived. Two hundred eighty-five metaphase II oocytes were microinjected for fertilization; 206 of them (72.3%) fertilized, and 53 embryos were transferred to 19 patients (in 20 warming cycles). Twenty-four of 53 transferred embryos (45.3%) implanted as confirmed by ultrasound examination. Of the 20 transfers, 16 resulted in clinical pregnancy (80%), 3 miscarried (15%), and 13 (65%) went on to produce 20 live births, respectively. This is much higher in comparison with our previous data using supernumerary oocytes where the rates of implantation and pregnancy were 6% and 21%. Live-birth rates per warmed oocyte and per injected oocyte were 5.1% and 7.2%, respectively.

Conclusion(s)

High pregnancy and implantation rates were observed after 6 months of cryopreservation by vitrification when oocytes from fertile woman were used. Proper screening of candidates for oocyte cryopreservation is of crucial importance to assure a favorable pregnancy outcome.

a Reproductive Medicine Associates of New Jersey, Morristown, New Jersey

b Naval Medical Center, San Diego, California

c CHA Fertility Center, Los Angeles, California

d Chabiotech Co. Ltd., Pochon CHA University, Seoul, South Korea

Corresponding Author InformationReprint requests: Seung Wook Hong, M.Sc., CHA Fertility Center, 5455 Wilshire Boulevard, Suite 1904, Los Angeles, CA 90036 (FAX: 323-525-3376).

 T.J.K. has nothing to disclose. L.R.L. has nothing to disclose. S.W.H. has nothing to disclose.

 Thomas J. Kim and Seung Wook Hong contributed equally to this study.

 Supported by a research grant from Organon USA Inc., a part of Schering-Plough Corporation.

PII: S0015-0282(08)04799-7

doi:10.1016/j.fertnstert.2008.12.094


View previous. 24 of 56 View next.